Your browser doesn't support javascript.
loading
Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial.
Soumerai, Jacob D; Mato, Anthony R; Dogan, Ahmet; Seshan, Venkatraman E; Joffe, Erel; Flaherty, Kelsey; Carter, Jason; Hochberg, Ephraim; Barnes, Jeffrey A; Hamilton, Audrey M; Abramson, Jeremy S; Batlevi, Connie L; Matasar, Matthew J; Noy, Ariela; Owens, Colette N; Palomba, M Lia; Kumar, Anita; Takvorian, Tak; Ni, Ai; Choma, Morgan; Friedman, Chaya; Chadha, Puja; Simkins, Elizabeth; Ruiters, Jade; Sechio, Sidney; Portman, Daneal; Ramos, Lauren; Nolet, Natascha; Mahajan, Neena; Martignetti, Rosalba; Mi, Joanna; Scorsune, Krista; Lynch, Julia; McGree, Brianne; Hughes, Stephanie; Grieve, Clare; Roeker, Lindsey E; Thompson, Meghan; Johnson, P Connor; Roshal, Mikhail; Huang, Jane; Biondo, Juliana; Wu, Qun; Jacob, Allison; Abdel-Wahab, Omar; Zelenetz, Andrew D.
Affiliation
  • Soumerai JD; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Mato AR; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Dogan A; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Seshan VE; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Joffe E; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Flaherty K; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Carter J; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Hochberg E; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Barnes JA; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Hamilton AM; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Abramson JS; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Batlevi CL; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Matasar MJ; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Noy A; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Owens CN; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Palomba ML; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Kumar A; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Takvorian T; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Ni A; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Choma M; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Friedman C; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Chadha P; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Simkins E; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Ruiters J; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Sechio S; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Portman D; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Ramos L; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Nolet N; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Mahajan N; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Martignetti R; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Mi J; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Scorsune K; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Lynch J; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • McGree B; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Hughes S; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Grieve C; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Roeker LE; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Thompson M; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Johnson PC; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Roshal M; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Huang J; Beigene, San Mateo, CA, USA.
  • Biondo J; Genentech, San Francisco, CA, USA.
  • Wu Q; Genentech, San Francisco, CA, USA.
  • Jacob A; Adaptive Biotechnologies, Seattle, WA, USA.
  • Abdel-Wahab O; Memorial-Sloan Kettering Cancer Center, New York, NY, USA.
  • Zelenetz AD; Memorial-Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: zeleneta@mskcc.org.
Lancet Haematol ; 8(12): e879-e890, 2021 Dec.
Article in En | MEDLINE | ID: mdl-34826411
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell Type of study: Clinical_trials / Guideline Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2021 Type: Article